Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo

Area of Science:

• Biomaterials Science
• Infectious Diseases
• Medical Device Innovation

Background:

• Gram-positive bacterial infections, particularly Staphylococcus species, pose a significant risk to implanted medical devices.
• Developing effective strategies to combat biofilms on these devices is crucial for patient safety and treatment outcomes.

Purpose of the Study:

• To investigate the efficacy of low-frequency ultrasound in enhancing vancomycin activity against Staphylococcus epidermidis biofilms on implanted medical devices.
• To determine the optimal duration of ultrasound treatment for eradicating Gram-positive bacterial biofilms.

Main Methods:

• Subcutaneous implantation of polyethylene disks with S. epidermidis biofilms in rabbits.
• Systemic administration of vancomycin to rabbits throughout the experiment.
• Insonation of implanted disks with low-frequency ultrasound for 24 or 48 hours, with a non-insonated control disk.

Main Results:

• No significant difference in viable bacteria counts between control and 24-hour insonated biofilms.
• Statistically significant reduction in viable bacteria in biofilms after 48 hours of insonation.
• S. epidermidis biofilms demonstrated a favorable response to the combination therapy, requiring longer treatment than previously observed for Gram-negative species.

Conclusions:

• Low-frequency ultrasound combined with vancomycin is a promising approach for treating Gram-positive bacterial infections on implanted medical devices.
• Extended ultrasound exposure (48 hours) is necessary to achieve significant bacterial reduction in S. epidermidis biofilms.
• Further research into optimizing ultrasound parameters and treatment durations is warranted for effective Gram-positive biofilm eradication.